Leucas Pharmaceuticals Private Limited

Leucas Pharmaceuticals Private Limited - pharma in Lucknow, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U51101UP2012PTC054313 Incorporated 21 December 2012 ROC Kanpur HQ Lucknow, Uttar Pradesh, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹23.44 Lakh
▲ 4% YoY
Net profit · FY 2024
₹51,737
Net margin 2.2%
EBITDA · FY 2024
₹1.14 Lakh
EBITDA margin 4.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹4 Lakh
Secured borrowings
Company age
14 yrs
Est. 2012
Directors on board
2
As per MCA filings

About Leucas Pharmaceuticals Private Limited

Data last updated:

Leucas Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 21 December 2012 and has been in existence for over 14 years.

The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51101UP2012PTC054313. Its GSTIN is 09AACCL8204A1ZX (Uttar Pradesh).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mohammad Shafeeq and Mohammad Nafees Ansari.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Lucknow, Uttar Pradesh.

As per the financials filed for FY 2024, the company reported a revenue of ₹23.44 Lakh, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹51,737 (net margin 2.2%) and EBITDA of ₹1.14 Lakh (EBITDA margin 4.9%). Revenue has grown at a compounded annual rate (CAGR) of 45% over three years.

As per MCA filings, the company has open charges of ₹4 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Leucas Pharmaceuticals Private Limited
CIN U51101UP2012PTC054313
Registration Number 054313
Incorporation Date 21 December 2012
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Plot No. 69 Harihar Nagar Near Hukum Singh School I, Ndra Nagar, Lucknow, Uttar Pradesh, India – 226028
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Leucas Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Leucas Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Leucas Pharmaceuticals Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Leucas Pharmaceuticals Private Limited

The main business activity of Leucas Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Leucas Pharmaceuticals Private Limited FY 2024 filings available

Leucas Pharmaceuticals Private Limited reported revenue of ₹23.44 Lakh (up 4% YoY) for FY 2024.

Revenue · FY 2024
₹23.44 Lakh ▲ 4%
Net profit · FY 2024
₹51,737 margin 2.2%
EBITDA · FY 2024
₹1.14 Lakh margin 4.9%

Compounded Annual Growth Rate (CAGR) of Leucas Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▲ 4%
3 years · compounded
▲ 45%
EBITDA CAGR growth
1 year
▲ 71%
3 years · compounded
▲ 118%
5 years · compounded
▲ 90%

Revenue has grown at a compounded annual rate (CAGR) of 45% over three years, including 4% growth in the latest year. EBITDA rose 71% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Leucas Pharmaceuticals Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹1.14 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹51,737••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Leucas Pharmaceuticals Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin4.9%••••••••••••••••
Net Profit Margin2.2%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Leucas Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Leucas Pharmaceuticals Private Limited

Leucas Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
V N Academy Private Limited₹23.51 Lakh (FY 2025)••••••••10.0%••••Kolkata, West Bengal, India
Sanier Pharmaceuticals Private Limited₹23.51 Lakh (FY 2025)••••••••24.0%••••Kannur, Kerala, India
Chandel Multi Health Trading Private Limited₹23.5 Lakh (FY 2024)••••••••-6.0%••••Bhopal, Madhya Pradesh, India
Ducwin Pharmaceuticals Private Limited₹23.5 Lakh (FY 2020)••••••••••••Ranchi, Jharkhand, India
Genome Pharmaceuticals and Chemicals Private Limited₹23.46 Lakh (FY 2025)••••••••81.0%••••Mumbai, Maharashtra, India
Leucas Pharmaceuticals Private Limited this company₹23.44 Lakh (FY 2024)••••••••4.0%••••Lucknow, Uttar Pradesh, India
Capital Pharmaceuticals Private Limited₹23.42 Lakh (FY 2024)••••••••0.0%••••Nani Daman, Daman and Diu, India
Glydous Pharmaceuticals Private Limited₹23.42 Lakh (FY 2025)••••••••-15.0%••••Gorakhpur, Uttar Pradesh, India
Paral Pharma Private Limited₹23.41 Lakh (FY 2025)••••••••-98.0%••••New Delhi, Delhi, India
Akshan Lifesciences Private Limited₹23.4 Lakh (FY 2025)••••••••9.0%••••Dhanbad, Jharkhand, India
Derma Swift Health Care Private Limited₹23.39 Lakh (FY 2025)••••••••51.0%••••New Delhi, Delhi, India

Peers are the five companies nearest above and the five nearest below Leucas Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Leucas Pharmaceuticals Private Limited

Leucas Pharmaceuticals Private Limited is audited by ARORA GUPTA & ASSOCIATES for the financial year 2017.

NameStatusAppointment DateCessation Date
ARORA GUPTA & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Leucas Pharmaceuticals Private Limited

Leucas Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Mohammad ShafeeqDirector21 Dec 201213 Years 9 MonthsCurrent
Mohammad Nafees AnsariDirector21 Dec 201213 Years 9 MonthsCurrent

Ownership and Shareholding of Leucas Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Leucas Pharmaceuticals Private Limited

Open charges
₹4 Lakh
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹0.04 Cr
Latest charge details
DateLenderAmountStatus
01 Sep 2023State Bank of India₹4 LakhOpen

Total charge records: 1 View all charges

Employees and EPFO Compliance at Leucas Pharmaceuticals Private Limited

Employment history and EPFO contributions of people linked to Leucas Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Leucas Pharmaceuticals Private Limited

Leucas Pharmaceuticals Private Limited has 2 board changes on record since 2012: 2 appointments. The latest: Mohammad Nafees Ansari was appointed as Director on 21 Dec 2012.

AGM
Leucas Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Leucas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur.
Charges
A charge with State Bank Of India amounted to Rs. 4.00 Lakh with Charge ID 100779235 was registered on 01 Sep 2023.
Appointed
Mohammad Nafees Ansari was appointed as Director.
Appointed
Mohammad Shafeeq was appointed as Director.
Incorporation
21 Dec 2012
Leucas Pharmaceuticals Private Limited was registered on 21 Dec 2012 with Roc Kanpur & aged 13 years 9 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Leucas Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Leucas Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Leucas Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Leucas Pharmaceuticals Private Limited

Leucas Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AACCL8204A1ZXUttar PradeshActive12 Dec 2019
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Leucas Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Leucas Pharmaceuticals Private Limited

Leucas Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 21 December 2012 (14+ years old) and is registered under CIN U51101UP2012PTC054313.

Leucas Pharmaceuticals reported revenue of ₹23.44 Lakh for FY 2024 (up 4% YoY).

Leucas Pharmaceuticals has 2 current directors:

Leucas Pharmaceuticals reported a net profit of ₹51,737 (net margin 2.2%) and EBITDA of ₹1.14 Lakh (EBITDA margin 4.9%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Leucas Pharmaceuticals is 45% over three years. In the latest year (FY 2024) revenue rose 4%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Leucas Pharmaceuticals is 09AACCL8204A1ZX, registered in Uttar Pradesh.

The CIN (Corporate Identification Number) of Leucas Pharmaceuticals is U51101UP2012PTC054313. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Leucas Pharmaceuticals was incorporated on 21 December 2012, making it 14+ years old. It is registered with the Registrar of Companies, Kanpur.

The peers of Leucas Pharmaceuticals by revenue are V N Academy Private Limited, Sanier Pharmaceuticals Private Limited, Chandel Multi Health Trading Private Limited, Ducwin Pharmaceuticals Private Limited, Genome Pharmaceuticals and Chemicals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).

Mohammad Nafees Ansari was appointed as Director on 21 Dec 2012. Mohammad Shafeeq was appointed as Director on 21 Dec 2012.

The registered office of Leucas Pharmaceuticals is at Plot No. 69 Harihar Nagar Near Hukum Singh School I, Ndra Nagar, Lucknow, Uttar Pradesh, India – 226028.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available